Canada
Some study participants stopped using cannabis out of fear of potential harm to the fetus, while others stopped because of social stigma, guilt and...
Hi, what are you looking for?
Mugglehead Investment Magazine
Medical and Pharmaceutical
Business
Initial deliveries have been made to local pharmacies with planned shipments for Germany and the UK
Business
Olorinab is a CB2 receptor agonist in a Phase 2 trial for IBS
Business
The firm will celebrate by ringing the opening bell at the stock exchange on Thursday
Health and Safety
Compared to non-consumers, people who used cannabis 20 days a month were more likely to experience both extremes of sleep duration
Business
The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services
Business
The company says it expects changes to Canadian law that will allow pharmacies to sell cannabis directly to patients
CBD
While THC can cause temporary dose-dependent psychotic symptoms, researchers note that some clinical findings suggest CBD has a different effect
Medical and Pharmaceutical
Research funded by MindMed suggests some antidepressants can reduce the unwanted side effects of psychedelics
International
A developed industry could be worth £1.2 billion and create about 41,000 jobs
